Researchers and art historians are examining how weight-loss drugs like Wegovy and Mounjaro are reshaping ideals of beauty in art. Prof. Rosalind Gill and Dr. Michael Yafi argue that the rapid fat loss caused by GLP-1 medications produces a distinctive gaunt facial appearance—dubbed 'GLP-1 face'—which could become a new aesthetic standard reflected in contemporary art, similar to 'heroin chic' in the 1990s. Yafi presented his findings at the European Congress on Obesity, noting that while artists like Fernando Botero continue to celebrate fuller figures, future artworks may increasingly depict thin individuals with hollowed features.
This matters because it highlights how medical and cultural shifts directly influence artistic representation and societal beauty standards. Historically, art portrayed high BMI as a sign of wealth and status, but the rise of weight-loss drugs may accelerate a preference for extreme thinness, raising questions about health, stigma, and the evolving definition of beauty. The discussion also underscores the role of consumer culture in commodifying new looks, with art serving as both a mirror and a driver of these changes.